Diana Lanchoney
Direttore/Membro del Consiglio presso Vitaeris, Inc.
Profilo
Diana Lanchoney is currently a Director at Vitaeris, Inc. She previously worked as an Independent Director at Diffusion Pharmaceuticals, Inc. and as an Associate Vice President-Corporate Strategy at Merck & Co., Inc. From 2014 to 2021, she worked at CSL Behring LLC, where she held the position of Vice President-Clinical Pharmacology from 2018 to 2021.
Dr. Lanchoney holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Tufts University.
Posizioni attive di Diana Lanchoney
Società | Posizione | Inizio |
---|---|---|
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Diana Lanchoney
Società | Posizione | Fine |
---|---|---|
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Corporate Officer/Principal | 01/12/2021 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
DIFFUSION PHARMA | Direttore/Membro del Consiglio | - |
Formazione di Diana Lanchoney
Tufts University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Aziende private | 3 |
---|---|
Diffusion Pharmaceuticals, Inc.
Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
Vitaeris, Inc.
Vitaeris, Inc. BiotechnologyHealth Technology Vitaeris, Inc. develops new treatment options for chronic inflammatory diseases. The company was founded by Kevin Chow, Patrick A. Robinson and Noel F. Hall in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Borsa valori
- Insiders
- Diana Lanchoney